ARase Therapeutics

Science focused oncology company

Leadership

Paul Chang, Ph.D.
President, CEO / CSO and Lead Founder

  • Lead founder of Ribon Therapeutics, and previously VP of Discovery Biology, Scientific Advisor and SAB member for Ribon
  • Previously the Howard and Linda Stern Assistant Professor at the Koch Institute for Integrative Cancer Research at MIT and the Department of Biology at MIT
  • Rita Allen Foundation fellow, Sidney Kimmel Foundation for Cancer Research fellow, recipient of a Kathy and Curt Marble Fund award, and multiple awards and grants from the NIH and Biopharma
  • Co-Chair and Organizer 2015 FASEB SRC conference, NAD+ Signaling and Metabolism, Chair and Organizer 2017 FASEB SRC conference, NAD+ Signaling and Metabolism

CFO
HR, Admin

Scientists

Director of Chemistry

Principal Scientist

Principal Scientist

Scientist
Irfan Bukhari Ph.D

Senior Scientist

Founders

Paul Chang Ph.D.
Lead Scientific Founder

W. Lee Kraus Ph.D.
Scientific Founder

Mission BioCapital
Founding Investor

Board

Paul Chang Ph.D.
President, CEO/CSO and Lead Founder

Michael Taylor Ph.D.
Executive Chair, Operating Partner, Mission BioCapital

Cassidy Blundell Ph.D.
Principal, Mission BioCapital

W. Lee Kraus Ph.D.
Founder